Change of outcomes in pediatric intestinal failure: Use of time-series analysis to assess the evolution of an intestinal rehabilitation program

Carol Oliveira, Nicole T. De Silva, Sanja Stanojevic, Yaron Avitzur, Ahmed M. Bayoumi, Wendy J. Ungar, Jeffrey S Hoch, Paul W. Wales

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background The clinical picture of pediatric intestinal failure has changed over the past 15 years, while effectiveness evolving treatment options remains unclear. This study explored evolution in care and quantified independent effects of new treatment options. Study Design Consecutive patients (n = 196) with neonatal or infantile intestinal failure, born between July 1996 and December 2011, were derived from an intestinal rehabilitation program (IRP) patient registry. Change over time was analyzed using multivariable Box-Jenkins method-based autoregressive integrative moving average models (ARIMA), robust linear regression, and nonparametric trend analysis. Four systematically introduced treatment options (IRP, serial transverse enteroplasty, omega-3 lipid emulsions, and ethanol locks) were evaluated. Analyses were adjusted for patient characteristics and disease severity. The primary outcome was disease-specific mortality from liver failure and sepsis. Secondary outcomes included parenteral nutrition weaning, transplantations, catheter complications, and liver disease. Results Patient characteristics remained unchanged over time, except for decreasing small bowel length (-0.5%/quarter; 95% CI -0.85, -0.16) and ICU admission time (-0.6 days/quarter; 95% CI -1.03, -0.18). Disease-specific mortality diminished significantly over time (-0.02 deaths/quarter; 95% CI -0.03, -0.01) by IRP and omega-3 lipids introduction (-0.6 deaths/quarter each, 95% CI -1.23, -0.02 and -0.77, -0.45, respectively). Serial transverse enteroplasty and ethanol locks had no significant impact. Parenteral nutrition weaning and transplantations remained unchanged, while catheter sepsis and complication rates decreased by 0.3 episodes/1,000 catheter-days each (95% CI -0.43, -0.2 and -0.45, -0.24, respectively). Conclusions Introduction of IRP and omega-3 lipids independently decreased disease-specific mortality. For the first time, time series analysis was applied to evaluate effectiveness of treatment options in intestinal rehabilitation.

Original languageEnglish (US)
Pages (from-to)1180-1188.e3
JournalJournal of the American College of Surgeons
Volume222
Issue number6
DOIs
StatePublished - Jun 1 2016
Externally publishedYes

Fingerprint

Rehabilitation
Pediatrics
Catheters
Parenteral Nutrition
Weaning
Lipids
Mortality
Sepsis
Ethanol
Transplantation
Liver Failure
Emulsions
Registries
Liver Diseases
Linear Models
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Change of outcomes in pediatric intestinal failure : Use of time-series analysis to assess the evolution of an intestinal rehabilitation program. / Oliveira, Carol; De Silva, Nicole T.; Stanojevic, Sanja; Avitzur, Yaron; Bayoumi, Ahmed M.; Ungar, Wendy J.; Hoch, Jeffrey S; Wales, Paul W.

In: Journal of the American College of Surgeons, Vol. 222, No. 6, 01.06.2016, p. 1180-1188.e3.

Research output: Contribution to journalArticle

Oliveira, Carol ; De Silva, Nicole T. ; Stanojevic, Sanja ; Avitzur, Yaron ; Bayoumi, Ahmed M. ; Ungar, Wendy J. ; Hoch, Jeffrey S ; Wales, Paul W. / Change of outcomes in pediatric intestinal failure : Use of time-series analysis to assess the evolution of an intestinal rehabilitation program. In: Journal of the American College of Surgeons. 2016 ; Vol. 222, No. 6. pp. 1180-1188.e3.
@article{25216b8d445f4932872bd8367ad5dd8c,
title = "Change of outcomes in pediatric intestinal failure: Use of time-series analysis to assess the evolution of an intestinal rehabilitation program",
abstract = "Background The clinical picture of pediatric intestinal failure has changed over the past 15 years, while effectiveness evolving treatment options remains unclear. This study explored evolution in care and quantified independent effects of new treatment options. Study Design Consecutive patients (n = 196) with neonatal or infantile intestinal failure, born between July 1996 and December 2011, were derived from an intestinal rehabilitation program (IRP) patient registry. Change over time was analyzed using multivariable Box-Jenkins method-based autoregressive integrative moving average models (ARIMA), robust linear regression, and nonparametric trend analysis. Four systematically introduced treatment options (IRP, serial transverse enteroplasty, omega-3 lipid emulsions, and ethanol locks) were evaluated. Analyses were adjusted for patient characteristics and disease severity. The primary outcome was disease-specific mortality from liver failure and sepsis. Secondary outcomes included parenteral nutrition weaning, transplantations, catheter complications, and liver disease. Results Patient characteristics remained unchanged over time, except for decreasing small bowel length (-0.5{\%}/quarter; 95{\%} CI -0.85, -0.16) and ICU admission time (-0.6 days/quarter; 95{\%} CI -1.03, -0.18). Disease-specific mortality diminished significantly over time (-0.02 deaths/quarter; 95{\%} CI -0.03, -0.01) by IRP and omega-3 lipids introduction (-0.6 deaths/quarter each, 95{\%} CI -1.23, -0.02 and -0.77, -0.45, respectively). Serial transverse enteroplasty and ethanol locks had no significant impact. Parenteral nutrition weaning and transplantations remained unchanged, while catheter sepsis and complication rates decreased by 0.3 episodes/1,000 catheter-days each (95{\%} CI -0.43, -0.2 and -0.45, -0.24, respectively). Conclusions Introduction of IRP and omega-3 lipids independently decreased disease-specific mortality. For the first time, time series analysis was applied to evaluate effectiveness of treatment options in intestinal rehabilitation.",
author = "Carol Oliveira and {De Silva}, {Nicole T.} and Sanja Stanojevic and Yaron Avitzur and Bayoumi, {Ahmed M.} and Ungar, {Wendy J.} and Hoch, {Jeffrey S} and Wales, {Paul W.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.jamcollsurg.2016.03.007",
language = "English (US)",
volume = "222",
pages = "1180--1188.e3",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Change of outcomes in pediatric intestinal failure

T2 - Use of time-series analysis to assess the evolution of an intestinal rehabilitation program

AU - Oliveira, Carol

AU - De Silva, Nicole T.

AU - Stanojevic, Sanja

AU - Avitzur, Yaron

AU - Bayoumi, Ahmed M.

AU - Ungar, Wendy J.

AU - Hoch, Jeffrey S

AU - Wales, Paul W.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background The clinical picture of pediatric intestinal failure has changed over the past 15 years, while effectiveness evolving treatment options remains unclear. This study explored evolution in care and quantified independent effects of new treatment options. Study Design Consecutive patients (n = 196) with neonatal or infantile intestinal failure, born between July 1996 and December 2011, were derived from an intestinal rehabilitation program (IRP) patient registry. Change over time was analyzed using multivariable Box-Jenkins method-based autoregressive integrative moving average models (ARIMA), robust linear regression, and nonparametric trend analysis. Four systematically introduced treatment options (IRP, serial transverse enteroplasty, omega-3 lipid emulsions, and ethanol locks) were evaluated. Analyses were adjusted for patient characteristics and disease severity. The primary outcome was disease-specific mortality from liver failure and sepsis. Secondary outcomes included parenteral nutrition weaning, transplantations, catheter complications, and liver disease. Results Patient characteristics remained unchanged over time, except for decreasing small bowel length (-0.5%/quarter; 95% CI -0.85, -0.16) and ICU admission time (-0.6 days/quarter; 95% CI -1.03, -0.18). Disease-specific mortality diminished significantly over time (-0.02 deaths/quarter; 95% CI -0.03, -0.01) by IRP and omega-3 lipids introduction (-0.6 deaths/quarter each, 95% CI -1.23, -0.02 and -0.77, -0.45, respectively). Serial transverse enteroplasty and ethanol locks had no significant impact. Parenteral nutrition weaning and transplantations remained unchanged, while catheter sepsis and complication rates decreased by 0.3 episodes/1,000 catheter-days each (95% CI -0.43, -0.2 and -0.45, -0.24, respectively). Conclusions Introduction of IRP and omega-3 lipids independently decreased disease-specific mortality. For the first time, time series analysis was applied to evaluate effectiveness of treatment options in intestinal rehabilitation.

AB - Background The clinical picture of pediatric intestinal failure has changed over the past 15 years, while effectiveness evolving treatment options remains unclear. This study explored evolution in care and quantified independent effects of new treatment options. Study Design Consecutive patients (n = 196) with neonatal or infantile intestinal failure, born between July 1996 and December 2011, were derived from an intestinal rehabilitation program (IRP) patient registry. Change over time was analyzed using multivariable Box-Jenkins method-based autoregressive integrative moving average models (ARIMA), robust linear regression, and nonparametric trend analysis. Four systematically introduced treatment options (IRP, serial transverse enteroplasty, omega-3 lipid emulsions, and ethanol locks) were evaluated. Analyses were adjusted for patient characteristics and disease severity. The primary outcome was disease-specific mortality from liver failure and sepsis. Secondary outcomes included parenteral nutrition weaning, transplantations, catheter complications, and liver disease. Results Patient characteristics remained unchanged over time, except for decreasing small bowel length (-0.5%/quarter; 95% CI -0.85, -0.16) and ICU admission time (-0.6 days/quarter; 95% CI -1.03, -0.18). Disease-specific mortality diminished significantly over time (-0.02 deaths/quarter; 95% CI -0.03, -0.01) by IRP and omega-3 lipids introduction (-0.6 deaths/quarter each, 95% CI -1.23, -0.02 and -0.77, -0.45, respectively). Serial transverse enteroplasty and ethanol locks had no significant impact. Parenteral nutrition weaning and transplantations remained unchanged, while catheter sepsis and complication rates decreased by 0.3 episodes/1,000 catheter-days each (95% CI -0.43, -0.2 and -0.45, -0.24, respectively). Conclusions Introduction of IRP and omega-3 lipids independently decreased disease-specific mortality. For the first time, time series analysis was applied to evaluate effectiveness of treatment options in intestinal rehabilitation.

UR - http://www.scopus.com/inward/record.url?scp=84969871852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969871852&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2016.03.007

DO - 10.1016/j.jamcollsurg.2016.03.007

M3 - Article

C2 - 27067452

AN - SCOPUS:84969871852

VL - 222

SP - 1180-1188.e3

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 6

ER -